Xu Wang

Xu Wang

Auto-generated profile, based on publicly available information

Xu Wang

The Affiliated Suqian Hospital of Xuzhou Medical University, Suqian, Jiangsu 223800, PR China

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 June 2026 in Nanoscale Horizons
Verified
Journal Article
Closed access
PDF file
NDNing Ding
Ning Ding
QYQing Yu
Qing Yu
ZSZiyuan Su
Ziyuan Su
YHYiting Han
Yiting Han
YCYajuan Chang
Yajuan Chang
XWXu Wang
Xu Wang
Suboptimal reactive oxygen species (ROS) production in photodynamic therapy (PDT) and chemodynamic therapy (CDT) due to tumor antioxidants and H2O2 constraints poses a challenge to their therapeutic efficacy. To address this, our study introduces GOx@MPN@Gel, a novel PDT/CDT platform that integrates glucose oxidase (GOx), luteolin, iron ions, a traditional Chinese medicine-inspired metal-phenolic network (MPN), and hydrogel (Gel) carriers to enhance ROS generation. Experimental results demonstrate GOx@MPN@Gel heightened acid sensitivity, robust GOx activity, and significant ROS production. Both in vitro and in vivo tests validate its therapeutic potential. Within the tumor microenvironment, GOx@MPN@Gel effectively elevates H2O2 levels for CDT, producing cytotoxic hydroxyl radicals (·OH), and upon near infrared (NIR) light exposure, its porphyrin component triggers potent PDT effects, generating additional ROS. This synergistic approach significantly enhances antitumor efficacy. The platform's unique design, combining acid-responsive degradation and PDT/CDT synergy, offers a promising personalized treatment strategy for breast cancer.

1 January 2026 in RSC Advances
Verified
Journal Article
Open access
YCYajuan Chang
Yajuan Chang
SLSunan Liu
Sunan Liu
XJXiaojuan Jin
Xiaojuan Jin
RSRuien Shi
Ruien Shi
YMYunsu Ma
Yunsu Ma
XWXu Wang
Xu Wang
A molecularly imprinted fluorescent probe (bCDs@MIP) was developed for selective detection of caffeic acid via fluorescence quenching. The method shows a LOD of 0.15 µM and was successfully applied to human serum analysis.